ArticleVirology journal2025
Phylogenetic and evolutionary analysis of VP1 coding sequences of foot-and-mouth disease virus serotypes A, O, and SAT2 in Egypt.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFoot-and-mouth disease (FMD) is a highly infectious viral disease caused by the foot-and-mouth disease virus (FMDV), which has seven serotypes requiring serotype-specific vaccines due to the absence of cross-protection. Understanding the genetic evolution of circulating strains is crucial for effective disease control and vaccine design. This study provides the first comprehensive evolutionary analysis of FMDV serotypes A, O, and SAT2 circulating in Egypt (1972-2022), integrating molecular clock modeling and structural analysis to uncover recent viral diversification. This study focused on analyzing the viral protein 1 (VP1) coding sequences from Egyptian field strains of serotypes A, O, and SAT2 using in silico approaches.
methodsThe nucleotide and amino acid sequences of VP1 for FMDV serotypes A, O, and SAT2 circulating in Egypt were retrieved from GenBank. Multiple sequence alignment was performed using ClustalW in MEGA 11, followed by phylogenetic tree construction using the maximum likelihood method with 1,000 bootstrap replicates. Pairwise identity matrices were generated to assess nucleotide similarities among isolates. Time-calibrated phylogenetic analyses were conducted using BEAST v2.6 to estimate substitution rates per site per year. Mutational analysis of the VP1 protein, particularly within the RGD (Arg-Gly-Asp) motif, was performed to identify novel amino acid substitutions with potential functional significance.
resultsMultiple sequence alignment, phylogenetic analysis, and identity matrix comparisons were conducted to evaluate genetic relationships, while time-calibrated phylogenetic analysis estimated substitution rates per site per year. Serotype A strains clustered within Asia and Africa topotypes, with the first detection of a novel Europe-South America (Europe-SA) topotype in Egypt. Serotype O strains were grouped into East Africa (EA-3), Middle East-South Asia (ME-SA), and another new Euro-SA topotype was identified in Sharqia Governorate. Serotype SAT2 strains consistently aligned with topotype VII, with clustering patterns noted in 2012 and 2018 isolates. Importantly, a novel G136S mutation was identified within the conserved RGD motif of the Menoufia strain (MG552839), representing the first report of this substitution. The estimated mean evolutionary rates were 2.23 × 10⁻³, 1.85 × 10⁻³, and 4.48 × 10⁻⁶ substitutions per site per year for serotypes A, O, and SAT2, respectively.
conclusionsThis study extends previous molecular investigations by including recent isolates from nearly all Egyptian governorates and integrating quantitative evolutionary rate estimation with structural analysis. The detection of new topotypes and unique mutations provides novel insights into FMDV evolution in Egypt and emphasizes the need for continuous molecular surveillance and periodic vaccine updates to maintain protection against emerging lineages.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.